Published in J Mol Biol on December 01, 2005
X-ray crystal structure of the rotavirus inner capsid particle at 3.8 A resolution. J Mol Biol (2010) 1.61
Group A human rotavirus genomics: evidence that gene constellations are influenced by viral protein interactions. J Virol (2008) 1.33
Vaccine-derived NSP2 segment in rotaviruses from vaccinated children with gastroenteritis in Nicaragua. Infect Genet Evol (2012) 1.06
Geometric mismatches within the concentric layers of rotavirus particles: a potential regulatory switch of viral particle transcription activity. J Virol (2008) 1.00
Molecular characterization of a subgroup specificity associated with the rotavirus inner capsid protein VP2. J Virol (2008) 0.86
Rotavirus NSP4 Triggers Secretion of Proinflammatory Cytokines from Macrophages via Toll-Like Receptor 2. J Virol (2013) 0.77
Molecular interactions in rotavirus assembly and uncoating seen by high-resolution cryo-EM. Proc Natl Acad Sci U S A (2009) 2.65
Lifetime costs of complications resulting from type 2 diabetes in the U.S. Diabetes Care (2002) 2.06
Structural organization of a filamentous influenza A virus. Proc Natl Acad Sci U S A (2010) 1.81
X-ray crystal structure of the rotavirus inner capsid particle at 3.8 A resolution. J Mol Biol (2010) 1.61
A structural model for maturation of the hepatitis B virus core. Proc Natl Acad Sci U S A (2005) 1.55
Cost-benefit analysis of preventing sudden cardiac deaths with an implantable cardioverter defibrillator versus amiodarone. Value Health (2007) 1.49
Economic implications of extended-release metoprolol succinate for heart failure in the MERIT-HF trial: a US perspective of the MERIT-HF trial. J Card Fail (2005) 1.43
Modeling the efficiency of reaching a target intermediate end point: a case study in type 2 diabetes in the United States. Value Health (2004) 1.39
Steroid-based facial amphiphiles for stabilization and crystallization of membrane proteins. Proc Natl Acad Sci U S A (2013) 1.06
Proton-linked dimerization of a retroviral capsid protein initiates capsid assembly. Structure (2009) 1.04
Pertussis immunization of adolescents in the United States: an economic evaluation. Pediatr Infect Dis J (2005) 1.02
Dissecting the 3-D structure of vimentin intermediate filaments by cryo-electron tomography. J Struct Biol (2006) 1.00
Membrane remodeling by the double-barrel scaffolding protein of poxvirus. PLoS Pathog (2011) 1.00
Rotavirus nonstructural glycoprotein NSP4 is secreted from the apical surfaces of polarized epithelial cells. J Virol (2006) 0.98
Model of the toxic complex of anthrax: responsive conformational changes in both the lethal factor and the protective antigen heptamer. Protein Sci (2006) 0.95
Health and economic consequences of an outbreak of pertussis among healthcare workers in a hospital in France. Infect Control Hosp Epidemiol (2005) 0.93
The time course of subsequent hospitalizations and associated costs in survivors of an ischemic stroke in Canada. BMC Health Serv Res (2006) 0.92
Rotavirus stimulates release of serotonin (5-HT) from human enterochromaffin cells and activates brain structures involved in nausea and vomiting. PLoS Pathog (2011) 0.92
Anthrax toxin-neutralizing antibody reconfigures the protective antigen heptamer into a supercomplex. Proc Natl Acad Sci U S A (2010) 0.92
A structural model for the generation of continuous curvature on the surface of a retroviral capsid. J Mol Biol (2012) 0.92
A case of an entrapped rotational atherectomy burr. Catheter Cardiovasc Interv (2002) 0.92
Optimized transduction of human monocyte-derived dendritic cells by recombinant adeno-associated virus serotype 6. Hum Gene Ther (2010) 0.90
Health and economic consequences of sevelamer use for hyperphosphatemia in patients on hemodialysis. Value Health (2005) 0.89
Large-scale structural changes accompany binding of lethal factor to anthrax protective antigen: a cryo-electron microscopic study. Structure (2004) 0.89
Protocol for a randomised controlled trial of a school based cognitive behaviour therapy (CBT) intervention to prevent depression in high risk adolescents (PROMISE). Trials (2010) 0.89
Cost-effectiveness of clopidogrel in acute coronary syndromes in Canada: a long-term analysis based on the CURE trial. Can J Cardiol (2007) 0.89
Structural polymorphism of oligomeric adiponectin visualized by electron microscopy. J Mol Biol (2008) 0.88
Proton-driven assembly of the Rous Sarcoma virus capsid protein results in the formation of icosahedral particles. J Biol Chem (2010) 0.88
Current preclinical models for the advancement of translational bladder cancer research. Mol Cancer Ther (2012) 0.87
Three-dimensional structure of the toxin-delivery particle antifeeding prophage of Serratia entomophila. J Biol Chem (2013) 0.87
The structure of the oligomerization domain of Lsr2 from Mycobacterium tuberculosis reveals a mechanism for chromosome organization and protection. PLoS One (2012) 0.86
Macrophage migratory inhibitory factor promotes bladder cancer progression via increasing proliferation and angiogenesis. Carcinogenesis (2013) 0.85
Quantifying the origins of population variability in cardiac electrical activity through sensitivity analysis of the electrocardiogram. J Physiol (2013) 0.85
An amino-terminal segment of hantavirus nucleocapsid protein presented on hepatitis B virus core particles induces a strong and highly cross-reactive antibody response in mice. Virology (2004) 0.85
Role of antifeeding prophage (Afp) protein Afp16 in terminating the length of the Afp tailocin and stabilizing its sheath. Mol Microbiol (2013) 0.85
Costs and medical care consequences associated with the diagnosis of peripheral arterial disease. Pharmacoeconomics (2005) 0.84
Structural study of the Serratia entomophila antifeeding prophage: three-dimensional structure of the helical sheath. J Bacteriol (2010) 0.84
Electron cryo-microscopy of TPPS4⋅2HCl tubes reveals a helical organisation explaining the origin of their chirality. Chemphyschem (2013) 0.83
Rotavirus NSP4 is secreted from infected cells as an oligomeric lipoprotein and binds to glycosaminoglycans on the surface of non-infected cells. Virol J (2011) 0.83
Cost effectiveness of tinzaparin sodium versus unfractionated heparin in the treatment of proximal deep vein thrombosis. Pharmacoeconomics (2002) 0.82
The potential of plant viral vectors and transgenic plants for subunit vaccine production. Adv Virus Res (2002) 0.82
Economic evaluation of atorvastatin for prevention of recurrent stroke based on the SPARCL trial. Value Health (2009) 0.82
Malignant peripheral nerve sheath tumor of the renal pelvis. Urol Int (2009) 0.81
APOBEC and iNOS are not the main intracellular effectors of IFN-gamma-mediated inactivation of Hepatitis B virus replication. Antiviral Res (2008) 0.81
Peroxiredoxin is a versatile self-assembling tecton for protein nanotechnology. Biomacromolecules (2014) 0.81
Cloud based toolbox for image analysis, processing and reconstruction tasks. Adv Exp Med Biol (2015) 0.81
Treating relapsing multiple sclerosis with subcutaneous versus intramuscular interferon-beta-1a: modelling the clinical and economic implications. Pharmacoeconomics (2009) 0.80
Oligomeric structure of colicin ia channel in lipid bilayer membranes. J Biol Chem (2009) 0.80
A PCR-directed cell-free approach to optimize protein expression using diverse fusion tags. Protein Expr Purif (2011) 0.79
Economic evaluation of galantamine in the treatment of mild to moderate Alzheimer's disease in the United States. Clin Ther (2003) 0.79
Automatic magnification determination of electron cryomicroscopy images using apoferritin as a standard. J Struct Biol (2012) 0.79
Transient osteoporosis of the hip: A case report. J Can Chiropr Assoc (2013) 0.78
Correlation of endorectal coil magnetic resonance imaging of the prostate with pathologic stage. World J Urol (2004) 0.78
Comminuted scapular body fractures: A report of three cases managed conservatively in chiropractic settings. J Can Chiropr Assoc (2013) 0.78
Transduction of human adipose-derived mesenchymal stem cells by recombinant adeno-associated virus vectors. Tissue Eng Part C Methods (2011) 0.78
Prognostic implications of lymph node involvement in bladder cancer: are we understaging using current methods? BJU Int (2011) 0.78
Rotavirus NSP4 Triggers Secretion of Proinflammatory Cytokines from Macrophages via Toll-Like Receptor 2. J Virol (2013) 0.77
A highly conserved tryptophan in the N-terminal variable domain regulates disulfide bond formation and oligomeric assembly of adiponectin. FEBS J (2012) 0.77
Primary non-Hodgkin's B-cell lymphoma of the male urethra presenting as stricture disease. Urology (2007) 0.77
Progress made in the use of animal models for the study of high-risk, nonmuscle invasive bladder cancer. Curr Opin Urol (2014) 0.77
Potent antietumor immunity in mice induced by vaccination with an ovine atadenovirus vector. J Immunother (2012) 0.77
Prevention and management of hyperphosphatemia with sevelamer in Canada: health and economic consequences. Value Health (2008) 0.77
Innovation in Bladder Cancer Immunotherapy. J Immunother (2016) 0.76
Cost-effectiveness of classroom-based cognitive behaviour therapy in reducing symptoms of depression in adolescents: a trial-based analysis. J Child Psychol Psychiatry (2014) 0.76
An investigation of the role of the adiponectin variable domain on the stability of the collagen-like domain. Biopolymers (2014) 0.76
Recombinant adeno-associated virus serotype 6 efficiently transduces primary human melanocytes. PLoS One (2013) 0.75
Letter to the Editor regarding TMDes(TM) Ear System article from CRANIO Volume 30 Issue 3, by Alejandro Tsuchiya Tavera, et al. Cranio (2015) 0.75
Ex vivo and In vivo Evaluation of Chitosan Coated Nanostructured Lipid Carriers for Ocular Delivery of Acyclovir. Curr Drug Deliv (2016) 0.75
Budgetary impact of treating acute bipolar mania in hospitalized patients with quetiapine: an economic analysis of clinical trials. Curr Med Res Opin (2006) 0.75
Lower urinary tract symptoms in the older male. Conn Med (2003) 0.75
Understanding the metal mediated assembly and hydrogel formation of a β-hairpin peptide. Biomater Sci (2017) 0.75
Cost-effectiveness of oral hypoglycaemic agents for the treatment of type 2 diabetes mellitus. Expert Opin Pharmacother (2005) 0.75